Vedanta Bio Names Ex-Genzyme Exec Roberts New CSO

Xconomy Boston — 

Vedanta Biosciences, a developer of microbiome drugs and an operating subsidiary of PureTech Health, has named Bruce Roberts its chief scientific officer. Roberts most recently led Genzyme’s neuro-immunology and immune-mediated disease research. He’ll now head up the R&D efforts of Vedanta, which recently opened a new headquarters and research facility in Cambridge.